Vir Biotechnology (VIR) Free Cash Flow (2018 - 2026)

Vir Biotechnology recorded quarterly Free Cash Flow of -$132.8 million in Q1 2026, down 406.31% quarter-over-quarter from -$26.2 million in Q4 2025, and down 66.5% year-over-year from -$396.4 million in Q1 2025.

Vir Biotechnology's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$132.8 million for Q1 2026.

  • In Q1 2026, Free Cash Flow fell 66.5% year-over-year to -$132.8 million; the TTM figure through Mar 2026 stood at -$449.6 million (down 6.52% YoY), while the FY2025 annual figure was -$396.6 million, up 12.57% from the prior year.
  • Free Cash Flow came in at -$132.8 million for Q1 2026 at Vir Biotechnology, down from -$26.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $939.5 million in Q2 2022 to a low of -$398.7 million in Q2 2023.
  • A 5-year average of -$11.1 million and a median of -$109.5 million in 2023 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow surged 694.22% in 2022 and plunged 585.38% in 2023, its largest moves.
  • Vir Biotechnology's Free Cash Flow stood at $22.6 million in 2022, then slumped by 585.38% to -$109.5 million in 2023, then climbed by 18.12% to -$89.6 million in 2024, then jumped by 70.74% to -$26.2 million in 2025, then slumped by 406.31% to -$132.8 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$132.8 million, -$26.2 million, and -$167.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.29 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 848.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67 Mn
10 Vir Biotechnology 1.33 Bn 1.33 Bn - -132.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -132.78 Mn
Mar 31, 2026 -132.78 Mn
Dec 31, 2025 -26.22 Mn
Dec 31, 2025 -26.22 Mn
Sep 30, 2025 -167.89 Mn
Sep 30, 2025 -167.89 Mn
Jun 30, 2025 -122.76 Mn
Jun 30, 2025 -122.76 Mn
Mar 31, 2025 -79.75 Mn
Mar 31, 2025 -79.75 Mn
Dec 31, 2024 -89.63 Mn
Dec 31, 2024 -89.63 Mn
Sep 30, 2024 -174.25 Mn
Sep 30, 2024 -174.25 Mn
Jun 30, 2024 -78.51 Mn
Jun 30, 2024 -78.51 Mn
Mar 31, 2024 -111.26 Mn
Mar 31, 2024 -111.26 Mn
Dec 31, 2023 -109.46 Mn
Dec 31, 2023 -109.46 Mn
Sep 30, 2023 -159.54 Mn
Sep 30, 2023 -159.54 Mn
Jun 30, 2023 -398.70 Mn
Jun 30, 2023 -398.70 Mn
Mar 31, 2023 -132.65 Mn
Mar 31, 2023 -132.65 Mn
Dec 31, 2022 22.55 Mn
Dec 31, 2022 22.55 Mn
Sep 30, 2022 98.91 Mn
Sep 30, 2022 98.91 Mn
Jun 30, 2022 939.54 Mn
Jun 30, 2022 939.54 Mn
Mar 31, 2022 534.25 Mn
Mar 31, 2022 534.25 Mn
Dec 31, 2021 -5.37 Mn
Dec 31, 2021 -5.37 Mn
Sep 30, 2021 -112.08 Mn
Sep 30, 2021 -112.08 Mn
Jun 30, 2021 137.95 Mn
Jun 30, 2021 137.95 Mn
Mar 31, 2021 -89.91 Mn
Mar 31, 2021 -89.91 Mn
Dec 31, 2020 -84.48 Mn
Dec 31, 2020 -84.48 Mn
Sep 30, 2020 -51.32 Mn
Sep 30, 2020 -51.32 Mn
Jun 30, 2020 -12.76 Mn
Jun 30, 2020 -12.76 Mn
Mar 31, 2020 -48.93 Mn
Mar 31, 2020 -48.93 Mn
Dec 31, 2019 -39.58 Mn
Dec 31, 2019 -39.58 Mn
Sep 30, 2019 -31.02 Mn
Sep 30, 2019 -31.02 Mn
Jun 30, 2019 -26.96 Mn
Jun 30, 2019 -26.96 Mn
Mar 31, 2019 -32.97 Mn
Mar 31, 2019 -32.97 Mn
Dec 31, 2018 -37.32 Mn
Dec 31, 2018 -37.32 Mn